(Q36945847)

17 August 2017

1 reference

title

Nucleoside analogue delivery systems in cancer therapy (English)

1 reference

17 August 2017

Roudayna Diab

1

1 reference

17 August 2017

Ghania Degobert

2

1 reference

17 August 2017

Misara Hamoudeh

3

1 reference

17 August 2017

Charles Dumontet

4

1 reference

17 August 2017

Hatem Fessi

5

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 September 2007

1 reference

Expert Opinion on Drug Delivery

17 August 2017

published in

1 reference

17 August 2017

volume

4

1 reference

17 August 2017

issue

5

1 reference

17 August 2017

page(s)

513-531

1 reference

Nucleoside analogues and nucleobases in cancer treatment.

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.513

The 5'-nucleotidases as regulators of nucleotide and drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.513

Nucleoside transporters in the disposition and targeting of nucleoside analogs in the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.513

Substrate specificity and phosphorylation of antiviral and anticancer nucleoside analogues by human deoxyribonucleoside kinases and ribonucleoside kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.513

Amino acid ester prodrugs of the anticancer agent gemcitabine: synthesis, bioconversion, metabolic bioevasion, and hPEPT1-mediated transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.513

Down-regulation of deoxycytidine kinase in human leukemic cell lines resistant to cladribine and clofarabine and increased ribonucleotide reductase activity contributes to fludarabine resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.513

cN-II expression predicts survival in patients receiving gemcitabine for advanced non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.513

Potential mechanisms of resistance to cytarabine in AML patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.513

Analytical and pharmacokinetic studies with 5-chloro-2'-deoxycytidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.513

Cytotoxicity and pharmacokinetics of cladribine metabolite, 2-chloroadenine in patients with leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.513

Liposomal formulations of anticancer drugs: selectivity and effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.513

Liposomal encapsulated anti-cancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.513

Cytotoxic effects of gemcitabine-loaded liposomes in human anaplastic thyroid carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.513

Clinical pharmacokinetics of cytarabine formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.513

Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.513

Design and development of multivesicular liposomal depot delivery system for controlled systemic delivery of acyclovir sodium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.513

5-Fluorouracil in vesicular phospholipid gels for anticancer treatment: entrapment and release properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.513

Cationic compounds used in lipoplexes and polyplexes for gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.513

Polyplex Nanogel formulations for drug delivery of cytotoxic nucleoside analogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.513

Cross-linked polymeric nanogel formulations of 5'-triphosphates of nucleoside analogues: role of the cellular membrane in drug release

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.513

Cytotoxicity of 5-fluorouracil entrapped in gelatin microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.513

Cytarabine release from comatrices of albumin microspheres in a poly(lactide-co-glycolide) film: in vitro and in vivo studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.513

Characterization of 5-fluorouracil microspheres for colonic delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.513

Development of a respirable, sustained release microcarrier for 5-fluorouracil I: In vitro assessment of liposomes, microspheres, and lipid coated nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.513

Clearance of microsphere-entrapped 5-fluorouracil and cytosine arabinoside from the vitreous of primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.513

Development of novel 5-FU-loaded poly(methylidene malonate 2.1.2)-based microspheres for the treatment of brain cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.513

Microsphere design for the colonic delivery of 5-fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.513

Biomedical applications of nanotechnology--implications for drug targeting and gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.513

Nanotechnology, nanomedicine, and the development of new, effective therapies for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.513

Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.513

Formulation and investigation of 5-FU nanoparticles with factorial design-based studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.513

Targeting of 3'-azido 3'-deoxythymidine (AZT)-loaded poly(isohexylcyanoacrylate) nanospheres to the gastrointestinal mucosa and associated lymphoid tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.513

Loading efficiency of stavudine on polybutylcyanoacrylate and methylmethacrylate-sulfopropylmethacrylate copolymer nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.513

Magnetic PECA nanoparticles as drug carriers for targeted delivery: synthesis and release characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.513

Preparation of poly epsilon-caprolactone nanoparticles containing magnetite for magnetic drug carrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.513

Dendrimers and dendritic polymers in drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.513

Dendrimers in biomedical applications--reflections on the field

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.513

Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.513

In vitro release of 5-fluorouracil with cyclic core dendritic polymer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.513

A PEGylated dendritic nanoparticulate carrier of fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.513

PEG-Ara-C conjugates for controlled release

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.513

Anticancer drug delivery systems: multi-loaded N4-acyl poly(ethylene glycol) prodrugs of ara-C. II. Efficacy in ascites and solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.513

Micellar nanocarriers: pharmaceutical perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.513

Micelle-like nanoparticles of star-branched PEO-PLA copolymers as chemotherapeutic carrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.513

Simultaneous sustained release of fludarabine monophosphate and Gd-DTPA from an interstitial liposome depot in rats: potential for indirect monitoring of drug release by magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.513

A lipid based depot (DepoFoam technology) for sustained release drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.5.513

21 January 2018

Identifiers

DOI

10.1517/17425247.4.5.513

1 reference

17 August 2017

1 reference